PL3862000T3 - Lek na przewlekły kaszel - Google Patents

Lek na przewlekły kaszel

Info

Publication number
PL3862000T3
PL3862000T3 PL19869380.6T PL19869380T PL3862000T3 PL 3862000 T3 PL3862000 T3 PL 3862000T3 PL 19869380 T PL19869380 T PL 19869380T PL 3862000 T3 PL3862000 T3 PL 3862000T3
Authority
PL
Poland
Prior art keywords
medicine
treating chronic
chronic cough
cough
treating
Prior art date
Application number
PL19869380.6T
Other languages
English (en)
Inventor
Ryuta Tamano
Erika Kasai
Sayaka Miyazaki
Katsue Magari
Original Assignee
Shionogi & Co., Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co., Ltd filed Critical Shionogi & Co., Ltd
Publication of PL3862000T3 publication Critical patent/PL3862000T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL19869380.6T 2018-10-05 2019-10-04 Lek na przewlekły kaszel PL3862000T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2018189791 2018-10-05
JP2019044943 2019-03-12
JP2019173841 2019-09-25
PCT/JP2019/039275 WO2020071530A1 (ja) 2018-10-05 2019-10-04 慢性咳嗽治療用医薬

Publications (1)

Publication Number Publication Date
PL3862000T3 true PL3862000T3 (pl) 2024-03-18

Family

ID=70054690

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19869380.6T PL3862000T3 (pl) 2018-10-05 2019-10-04 Lek na przewlekły kaszel

Country Status (16)

Country Link
US (1) US11883407B2 (pl)
EP (1) EP3862000B1 (pl)
JP (2) JP6725188B1 (pl)
KR (1) KR102613204B1 (pl)
CN (2) CN113164488A (pl)
AU (1) AU2019353424B2 (pl)
BR (1) BR112021005334A2 (pl)
CA (1) CA3115649A1 (pl)
ES (1) ES2963702T3 (pl)
IL (1) IL282007A (pl)
MX (1) MX2021003686A (pl)
PH (1) PH12021550713A1 (pl)
PL (1) PL3862000T3 (pl)
TW (1) TWI804687B (pl)
WO (1) WO2020071530A1 (pl)
ZA (1) ZA202101756B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI889708B (zh) 2019-09-19 2025-07-11 日商塩野義製藥股份有限公司 1,3,5-三衍生物或其溶劑合物之結晶及其製造方法
TW202203929A (zh) 2020-04-03 2022-02-01 日商塩野義製藥股份有限公司 疼痛治療用醫藥
EP4151219A4 (en) * 2020-05-15 2024-05-15 Shionogi & Co., Ltd DRUG COMPOSITION WITH INHIBITED IMPURITIES PRODUCTION
CN113620888B (zh) * 2021-09-27 2023-06-06 成都施贝康生物医药科技有限公司 二氢嘧啶类化合物及其制备方法和应用
CN113773300B (zh) * 2021-09-27 2022-10-11 成都施贝康生物医药科技有限公司 磺酰胺类化合物、其制备方法及用途
CN113801097B (zh) * 2021-09-27 2022-11-22 成都施贝康生物医药科技有限公司 二氢嘧啶类化合物、其制备方法及用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008507368A (ja) 2004-07-22 2008-03-13 デュスカ サイエンティフィック カンパニー 肺疾患を診断、モニタリングおよび治療するための方法
CN1915311A (zh) 2006-08-17 2007-02-21 胡国良 一种治疗顽固性咳嗽的汤剂药物及制备方法
CN103153968B (zh) 2010-08-10 2016-02-03 盐野义制药株式会社 三唑衍生物及含有其的具有镇痛作用的药物组合物
DK3381917T3 (da) 2013-01-31 2021-10-18 Bellus Health Cough Inc Imidazopyridinforbindelser og anvendelser deraf
TWI637949B (zh) 2013-06-14 2018-10-11 塩野義製藥股份有限公司 胺基三衍生物及含有其等之醫藥組合物
AU2014308606B2 (en) * 2013-08-23 2017-08-03 Afferent Pharmaceuticals Inc. Diaminopyrimidine P2X3 and P2X 2/3 receptor modulators for treatment of acute, sub-acute or chronic cough
CN105582039A (zh) 2014-11-10 2016-05-18 刘丰涛 一种治疗干咳痰少的药物
EP3230281B1 (en) 2014-12-09 2021-05-26 Bayer Aktiengesellschaft 1,3-thiazol-2-yl substituted benzamides
DK3355889T3 (da) * 2015-09-29 2023-05-15 Afferent Pharmaceuticals Inc Diaminopyrimidin-p2x3- og p2x2/3-receptormodulatorer til anvendelse i behandling af hoste
US10111883B1 (en) * 2017-09-18 2018-10-30 Bellus Health Cough Inc. Selective P2X3 modulators
EA202092678A1 (ru) 2018-05-15 2021-04-12 Байер Акциенгезельшафт 1,3-тиазол-2-ил-замещенные бензамиды для лечения заболеваний, ассоциированных с сенситизацией нервных волокон

Also Published As

Publication number Publication date
JPWO2020071530A1 (ja) 2021-02-15
TW202027751A (zh) 2020-08-01
PH12021550713A1 (en) 2021-11-22
BR112021005334A2 (pt) 2021-06-15
EP3862000A4 (en) 2022-07-06
JP2021054800A (ja) 2021-04-08
US11883407B2 (en) 2024-01-30
AU2019353424A1 (en) 2021-05-06
MX2021003686A (es) 2021-06-04
WO2020071530A1 (ja) 2020-04-09
CA3115649A1 (en) 2020-04-09
CN113559104A (zh) 2021-10-29
IL282007A (en) 2021-05-31
KR102613204B1 (ko) 2023-12-12
ES2963702T3 (es) 2024-04-01
EP3862000C0 (en) 2023-10-18
JP6725188B1 (ja) 2020-07-15
TWI804687B (zh) 2023-06-11
CN113164488A (zh) 2021-07-23
US20210393640A1 (en) 2021-12-23
ZA202101756B (en) 2023-06-28
EP3862000A1 (en) 2021-08-11
EP3862000B1 (en) 2023-10-18
AU2019353424B2 (en) 2022-12-08
KR20210064273A (ko) 2021-06-02

Similar Documents

Publication Publication Date Title
GB201804255D0 (en) Macrophage-based therapy
PL3862000T3 (pl) Lek na przewlekły kaszel
IL249231A0 (en) Pharmaceutical combinations for cancer treatment
GB201813876D0 (en) Treatment
ZA201900052B (en) Pharmaceutical combinations for treating cancer
LT3377064T (lt) Orvepitantas, skirtas lėtinio kosulio gydymui
GB201819853D0 (en) Therapy
IL273044A (en) Pridopidine for the treatment of drug-induced dyskinesia
PL3129378T3 (pl) Związki hamujące bromodomenę i zawierająca je kompozycja farmaceutyczna do zapobiegania lub leczenia nowotworu
IL255079A0 (en) Methods of treating lung cancer
IL268416A (en) Pharmaceutical combinations for cancer treatment
IL261010B (en) Compositions and methods for treating chronic wounds
GB201800546D0 (en) Treatment
EP3256473A4 (en) Synergistic cancer treatment
GB2575637B (en) Radiotherapy apparatus
SG11202102878TA (en) Treatment methods
SG11202102827YA (en) Treatment methods
SI3406258T1 (sl) Zdravilo za zdravljenje putike
IL283273A (en) Pharmacy practices
GB201817385D0 (en) Therapy
GB201820895D0 (en) Therapy
GB201814905D0 (en) Treatment
IL262221A (en) Treat ments forcahcers etc
GB201814038D0 (en) Ilven therapy
GB201805557D0 (en) Therapy for ophthalmogical condtions